These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 35041907

  • 41. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.
    Sullivan NR, Crane JW, Damjanoska KJ, Carrasco GA, D'Souza DN, Garcia F, Van de Kar LD.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):18-26. PubMed ID: 15655673
    [Abstract] [Full Text] [Related]

  • 42. Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences.
    Marchette RCN, Carlson ER, Frye EV, Hastings LE, Vendruscolo JCM, Mejias-Torres G, Lewis SJ, Hampson A, Volkow ND, Vendruscolo LF, Koob GF.
    J Pharmacol Exp Ther; 2023 May; 385(2):117-134. PubMed ID: 36828628
    [Abstract] [Full Text] [Related]

  • 43. Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.
    Guenther U, Theuerkauf NU, Huse D, Boettcher MF, Wensing G, Putensen C, Hoeft A.
    Anesthesiology; 2012 Jan; 116(1):56-64. PubMed ID: 22082683
    [Abstract] [Full Text] [Related]

  • 44. A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.
    Raleigh MD, Baruffaldi F, Peterson SJ, Le Naour M, Harmon TM, Vigliaturo JR, Pentel PR, Pravetoni M.
    J Pharmacol Exp Ther; 2019 Feb; 368(2):282-291. PubMed ID: 30409833
    [Abstract] [Full Text] [Related]

  • 45. The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats.
    Crowley ML, Restrepo LF, Gamez-Jimenez LR, Patel A, Braun T, Pallares VLC, Ho NP, Reeves ME, McCurdy CR, McMahon LR, Hiranita T.
    J Pharmacol Toxicol Methods; 2021 Feb; 111():107101. PubMed ID: 34242797
    [Abstract] [Full Text] [Related]

  • 46. Dose-Dependent Efficacy of Tandospirone for an Oldest-Old Patient With Behavioral and Psychological Symptoms of Dementia.
    Ochi S, Mori T, Iga JI, Ueno SI.
    J Clin Psychopharmacol; 2019 Feb; 39(2):176-178. PubMed ID: 30628997
    [No Abstract] [Full Text] [Related]

  • 47. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
    Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Uehara T, Kurachi M, Meltzer HY.
    J Clin Psychopharmacol; 2000 Jun; 20(3):386-8. PubMed ID: 10831031
    [No Abstract] [Full Text] [Related]

  • 48. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.
    Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer HY.
    Am J Psychiatry; 2001 Oct; 158(10):1722-5. PubMed ID: 11579010
    [Abstract] [Full Text] [Related]

  • 49. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.
    Sukhtankar DD, Lee H, Rice KC, Ko MC.
    Psychopharmacology (Berl); 2014 Apr; 231(7):1377-87. PubMed ID: 24217900
    [Abstract] [Full Text] [Related]

  • 50. A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
    Sato S, Mizukami K, Asada T.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):281-3. PubMed ID: 16817981
    [Abstract] [Full Text] [Related]

  • 51. Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.
    Zwicker JD, Zhang Y, Ren J, Hutchinson MR, Rice KC, Watkins LR, Greer JJ, Funk GD.
    J Appl Physiol (1985); 2014 Oct 15; 117(8):857-68. PubMed ID: 25103966
    [Abstract] [Full Text] [Related]

  • 52. A brain-targeted ampakine compound protects against opioid-induced respiratory depression.
    Dai W, Xiao D, Gao X, Zhou XB, Fang TY, Yong Z, Su RB.
    Eur J Pharmacol; 2017 Aug 15; 809():122-129. PubMed ID: 28502631
    [Abstract] [Full Text] [Related]

  • 53. Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.
    Takei A, Hamada S, Homma S, Hamada K, Tashiro K, Hamada T.
    Cerebellum; 2010 Dec 15; 9(4):567-70. PubMed ID: 20809107
    [Abstract] [Full Text] [Related]

  • 54. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
    Yi SP, Kong QH, Li YL, Pan CL, Yu J, Cui BQ, Wang YF, Wang GL, Zhou PL, Wang LL, Gong ZH, Su RB, Shen YH, Yu G, Chang KJ.
    Acta Pharmacol Sin; 2017 Jul 15; 38(7):977-989. PubMed ID: 28502978
    [Abstract] [Full Text] [Related]

  • 55. Non-analgesic effects of opioids: opioid-induced respiratory depression.
    Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A.
    Curr Pharm Des; 2012 Jul 15; 18(37):5994-6004. PubMed ID: 22747535
    [Abstract] [Full Text] [Related]

  • 56. Evidence for the emergence of an opioid-resistant respiratory rhythm following fentanyl overdose.
    Haouzi P, Mellen N, McCann M, Sternick M, Guck D, Tubbs N.
    Respir Physiol Neurobiol; 2020 Jun 15; 277():103428. PubMed ID: 32151709
    [Abstract] [Full Text] [Related]

  • 57. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats.
    Bobeck EN, Schoo SM, Ingram SL, Morgan MM.
    J Pain; 2019 Sep 15; 20(9):1040-1047. PubMed ID: 30853505
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
    Godbout R, Chaput Y, Blier P, de Montigny C.
    Neuropharmacology; 1991 Jul 15; 30(7):679-90. PubMed ID: 1681446
    [Abstract] [Full Text] [Related]

  • 60. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T, Noda T, Satomi M, Ohtaki K, Chiba K, Tasaki Y, Shiono H.
    Brain Res; 2006 Sep 27; 1112(1):126-33. PubMed ID: 16884702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.